VanEck S&P/ASX MidCap ETF (MVE) Review & Analysis

MER Β· Top 50%AUM Β· Top 50%1Y Return Β· #328 of 4263Y Return Β· #161 of 3005Y Return Β· Top 50%
What's new this monthData to 30 September 2026
  • βˆ’3.3% in September (total return), behind the median Australian shares ETF at βˆ’2.1%.
  • Investors added a net $4.4m (0.9% of the fund).
  • The unit price closed the month at $44.09, 7% below its 12-month high (range $39.39 to $47.44).

About MVE

MVE is an Australian shares ETF from VanEck, listed on the ASX since October 2013. With $499m under management it is number 28 of 81 Australian shares ETFs by size. The management fee is 0.45% a year, about $45 on every $10,000 invested, dearer than the typical Australian shares ETF at 0.35%.

Its largest holdings are Pro Medicus Ltd, Ramsay Health Care Ltd and Orica Ltd, and the top 10 make up 30% of the fund. By sector it leans towards materials (23%) and health care (15%).

Over five years it has returned +6.0% a year including distributions, against +5.9% for the median Australian shares ETF.

MVE distributions and dividend dates

MVE pays distributions half-yearly, usually going ex-distribution in January and July, with payment about 26 days after the ex-date. (Pattern estimated from recent payments.)

The latest distribution was $0.63 per unit (48% franked), ex-distribution on 1 July 2026 and paid on 27 July 2026. To receive it you need to own MVE before the ex-date.

Its distribution yield over the past 12 months is about 2.6%, with distributions around 48% franked. Distributions vary and past payments are not a guide to future ones.

From ASX announcements, updated nightly. See every ETF in the dividend calendar.

Compare MVE with

MVE price by TradingView

Stock CodeMVE
Fund ManagerVanEck
Asset ClassAustralian shares
AUM$499m
MER (%)0.45%
Net flows (Sep)+$4.4m
Last Price$44.09
52-Week Range$39.39 – $47.44
Bid/Ask Spread0.05%
Listing Date16/10/2013
ExchangeASX
Index trackedS&P/ASX MidCap 50 Index
Issuer websiteVanEck β†—

Performance (% return)

-3%9%22%34%1M-3.3%1Y-1.5%3Y34.3%5Y34.1%
1 monthβˆ’3.3%
1 yearβˆ’1.5%
3 years p.a.+10.3%
5 years p.a.+6.0%

$10,000 invested…

1 year ago$9,8483 years ago$13,4275 years ago$13,410

Value at 30 September 2026 with distributions reinvested, before tax and brokerage.

Total returns including distributions, to 30 September 2026. 1M, 1Y, 3Y and 5Y bars are cumulative.

MVE at a glance: strengths and things to watch

πŸ‘ Strengths

  • Cheap to trade. A bid/ask spread of 0.05%, so buying and selling costs little extra.
  • Long track record. Listed since 2013, through several market cycles.
  • In an uptrend. Its price has been trending up since 6 November (as at 7 November).

⚠️ Things to watch

  • Nothing stands out against its category.

Worked out from MVE's fees, size, flows, returns and trend against the 83 Australian shares ETFs in Australia, to 30 September 2026. General information, not a recommendation.

Joshua StegaetfadviserTrend check
Uptrend since 6 Nov 2026

MVE is in an uptrend. Here's why that matters.

MVE's price is above its 20-day average and its 10, 20, 50 and 200-day averages are stacked upward. The trend is on investors' side. Its price is 3.2% below its 12-month high.

Why it matters: Uptrends are when satellite ETFs tend to do their best work. The key is knowing when the trend breaks, so gains aren't handed back.

At ETF Adviser the core of a portfolio stays invested through every stage, and satellite ETFs are only bought in an uptrend. Members get a weekly update on which ETFs are breaking out of a base and which trends have broken.

Oct 25Jan 26Apr 26Jul 26Oct 26
UptrendBaseDowntrend

MVE weekly price, past 12 months, shaded by trend stage. Stage as at 7 November 2026, updated weekly. A technical label, not a recommendation.

MVE vs its benchmark

How MVE has done against the S&P/ASX MidCap 50 Index, after fees. For an index fund, a small shortfall roughly the size of the fee is normal.

MVEBenchmarkDifference
1 year-1.72%-1.24%-0.48%
3 years p.a.+10.72%+11.25%-0.53%
5 years p.a.+6.52%+7.03%-0.51%

Issuer figures to 30 September 2026, fund returns after fees. Source: VanEck. Compare more ETFs vs their benchmark β†’

Investment Focus

Exposure Regions

Australia

Portfolio Breakdown

Top 10 holdings (29.8% of the fund)

SymbolCompany% assets
PME3.33%
RHC3.22%
ORI3.22%
CHC2.99%
VCX2.94%
SFR2.88%
COH2.88%
ALD2.79%
TNE2.79%
WTC2.73%

Sector breakdown

  • Materials23.2%
  • Health Care15.1%
  • Financials12.6%
  • Real Estate10.3%
  • Industrials9.6%
  • Information Technology9.2%
  • Energy5.9%
  • Consumer Staples4.6%
  • Other9.3%

Holdings from the issuer's published portfolio as at 30 October 2026. Breakdowns are based on the largest 51 positions, covering 100% of the fund. Compare MVE's holdings with other ETFs β†’

Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.

Similar ETFs

CodeNameSame holdingsMERAUM1Y3Y p.a.5Y p.a.
VSOVanguard MSCI Australian Small Companies Index ETF
46%
0.30%$1.2bnβˆ’0.1%+11.5%+4.8%
MVWVanEck Australian Equal Weight ETF
39%
0.35%$3.3bn+0.8%+8.7%+6.3%
EX20Betashares Australian Ex-20 Portfolio Diversifier ETF
33%
0.25%$676mβˆ’4.5%+9.0%+4.2%
MVRVanEck Australian Resources ETF
29%
0.35%$836m+24.9%+11.9%+13.7%
FAIRBetashares Australian Sustainability Leaders ETF
26%
0.49%$1.0bnβˆ’12.5%+4.7%+1.2%
AQLTBetashares Australian Quality ETF
22%
0.35%$1.5bn+5.3%+16.9%–

Same holdings is the share of MVE's money in companies the other ETF also holds, weighted by size. Most similar first, then ETFs in the same category. See every ETF like MVE β†’

MVE vs its closest alternatives

What actually differs between MVE and the ETFs most like it. Data to 30 Sep 2026.

VSO Vanguard MSCI Australian Small Companies Index ETF

  • They share 46% of their holdings: some overlap.
  • VSO is cheaper (0.30% vs 0.45%), worth about $10,150 on $100,000 over 20 years.
  • Over 3 years, a year: MVE +10.3%, VSO +11.5% (VSO ahead by 1.2 percentage points).
  • VSO is about 2 times larger ($1.2bn vs $499m), which usually means tighter trading spreads.

Compare MVE and VSO side by side β†’

MVW VanEck Australian Equal Weight ETF

  • They share 39% of their holdings: some overlap.
  • MVW is cheaper (0.35% vs 0.45%), worth about $6,736 on $100,000 over 20 years.
  • Over 3 years, a year: MVE +10.3%, MVW +8.7% (MVE ahead by 1.6 percentage points).
  • MVW is about 7 times larger ($3.3bn vs $499m), which usually means tighter trading spreads.

Compare MVE and MVW side by side β†’

EX20 Betashares Australian Ex-20 Portfolio Diversifier ETF

  • They share 33% of their holdings: some overlap.
  • EX20 is cheaper (0.25% vs 0.45%), worth about $13,594 on $100,000 over 20 years.
  • Over 3 years, a year: MVE +10.3%, EX20 +9.0% (MVE ahead by 1.3 percentage points).

Compare MVE and EX20 side by side β†’

General information only. Past performance is not a reliable indicator of future performance.

Popular comparisons

IOZ vs MVESTW vs MVEILC vs MVE

MVE FAQs

What is the fee for MVE?

MVE charges a management fee (MER) of 0.45% a year, according to the TMX Australia monthly funds report as at 30 September 2026.

How big is MVE?

MVE had $499m in funds under management as at 30 September 2026.

How has MVE performed?

MVE returned βˆ’1.5% over the year to 30 September 2026 (total return, including distributions). Over three years it returned +10.3% a year. Past performance is not a reliable indicator of future performance.

Who manages MVE?

MVE is managed by VanEck and has been listed since October 2013.

What does MVE hold?

MVE's largest holdings are Pro Medicus Ltd (3.3%), Ramsay Health Care Ltd (3.2%), Orica Ltd (3.2%), Charter Hall Group (3.0%), Vicinity Ltd (2.9%). It holds about 51 investments in total. The biggest sector is materials at 23%. Holdings as at 30 October 2026.

Disclaimer

This review is general information only and does not take into account your objectives, financial situation or needs. Consider the VanEck product disclosure statement (PDS) and target market determination (TMD) before investing. Past performance is not a reliable indicator of future performance.